Egyptian International Pharmaceutical Industries Company (EGX:PHAR)

Egypt flag Egypt · Delayed Price · Currency is EGP
80.04
-2.70 (-3.26%)
At close: Oct 23, 2025
-3.26%
Market Cap13.96B
Revenue (ttm)8.82B
Net Income (ttm)1.14B
Shares Out168.76M
EPS (ttm)7.65
PE Ratio10.82
Forward PE10.90
Dividend1.50 (1.81%)
Ex-Dividend DateApr 22, 2025
Volume953,032
Average Volume656,557
Open82.74
Previous Close82.74
Day's Range79.12 - 83.43
52-Week Range43.50 - 83.99
Beta0.46
RSI72.40
Earnings DateNov 13, 2025

About EGX:PHAR

Egyptian International Pharmaceutical Industries Company manufactures and sells pharmaceutical ampoules in Egypt and internationally. The company offers analgesics and antipyretic; analgesics and anti-inflammatory; anti-infective; antihistamine; cardiovascular and metabolic; corticosteroids; gastrointestinal tract; nervous system; ophthalmic; respiratory; topical ointment and cream; vitamins; and miscellaneous products. It also exports its products. Egyptian International Pharmaceutical Industries Company was incorporated in 1980 and is based i... [Read more]

Industry Pharmaceutical Preparations
Founded 1980
Country Egypt
Stock Exchange Egyptian Stock Exchange
Ticker Symbol PHAR
Full Company Profile

Financial Performance

In 2024, EGX:PHAR's revenue was 7.59 billion, an increase of 45.09% compared to the previous year's 5.23 billion. Earnings were 1.10 billion, an increase of 33.25%.

Financial Statements

News

There is no news available yet.